| NCT03682055 |
Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) |
https://ClinicalTrials.gov/show/NCT03682055 |
Active, not recruiting |
Cullinan Oncology, LLC |
2021-10-31 |
| NCT03401229 |
Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis |
https://ClinicalTrials.gov/show/NCT03401229 |
Active, not recruiting |
AstraZeneca |
2020-08-07 |
| NCT03323866 |
Mometasone vs Budesonide in CRS With Polyposis |
https://ClinicalTrials.gov/show/NCT03323866 |
Recruiting |
Université de Sherbrooke |
2020-10-31 |
| NCT03282617 |
Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03282617 |
Recruiting |
National University Hospital, Singapore |
2019-08-14 |
| NCT03196869 |
the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03196869 |
Recruiting |
Guiyang Medical University |
2019-04-12 |
| NCT03175939 |
Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03175939 |
Completed |
Sun Yat-sen University |
2008-12-31 |
| NCT03144661 |
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies |
https://ClinicalTrials.gov/show/NCT03144661 |
Recruiting |
Incyte Corporation |
2021-02-28 |
| NCT03129412 |
Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions |
https://ClinicalTrials.gov/show/NCT03129412 |
Recruiting |
Zhejiang Cancer Hospital |
2023-04-23 |
| NCT03096808 |
Adaptive Radiotherapy for Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT03096808 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-03-15 |
| NCT03095703 |
Sirolimus and Familial Adenomatous Polyposis (FAP) |
https://ClinicalTrials.gov/show/NCT03095703 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2018-12-10 |
| NCT03082534 |
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03082534 |
Recruiting |
University of California, San Diego |
2019-12-30 |
| NCT03010813 |
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery |
https://ClinicalTrials.gov/show/NCT03010813 |
Completed |
Chinese University of Hong Kong |
2017-10-31 |
| NCT03007836 |
High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03007836 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2017-12-01 |
| NCT02961374 |
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer |
https://ClinicalTrials.gov/show/NCT02961374 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-02-23 |
| NCT02915445 |
EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer |
https://ClinicalTrials.gov/show/NCT02915445 |
Recruiting |
Sichuan University |
2020-07-31 |
| NCT02902432 |
A Trial of Endostar in Patients With Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT02902432 |
Active, not recruiting |
China International Medical Foundation |
2017-12-20 |
| NCT02874651 |
ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy |
https://ClinicalTrials.gov/show/NCT02874651 |
Recruiting |
Sun Yat-sen University |
2021-06-30 |
| NCT02784262 |
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis |
https://ClinicalTrials.gov/show/NCT02784262 |
Completed |
Norwegian University of Science and Technology |
2018-09-04 |
| NCT02734849 |
Study to Evaluate Multiple Doses in Patients With Nasal Polyposis |
https://ClinicalTrials.gov/show/NCT02734849 |
Completed |
Allakos, Inc. |
2018-01-31 |
| NCT02627807 |
Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT02627807 |
Active, not recruiting |
Sun Yat-sen University |
2020-12-31 |
| NCT02611960 |
Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122) |
https://ClinicalTrials.gov/show/NCT02611960 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2020-11-30 |
| NCT02608073 |
A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02608073 |
Completed |
Hoffmann-La Roche |
2009-11-30 |
| NCT02592603 |
Endocuff for Surveillance of Serrated Polyposis Syndrome |
https://ClinicalTrials.gov/show/NCT02592603 |
Completed |
Hospital Clinic of Barcelona |
2017-07-31 |
| NCT02562924 |
The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery |
https://ClinicalTrials.gov/show/NCT02562924 |
Completed |
University of Vermont Medical Center |
2017-12-31 |
| NCT02507154 |
Reactivating NK Cells in Treating Refractory Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT02507154 |
Recruiting |
National University Hospital, Singapore |
2019-08-31 |
| NCT02456506 |
Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma. |
https://ClinicalTrials.gov/show/NCT02456506 |
Active, not recruiting |
Sun Yat-sen University |
2022-12-31 |
| NCT02444949 |
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT02444949 |
Completed |
China Three Gorges University, Yichang, China |
2016-12-31 |
| NCT02360501 |
Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT02360501 |
Completed |
Sun Yat-sen University |
2016-03-31 |
| NCT02269943 |
Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT02269943 |
Completed |
Celgene |
2017-04-20 |
| NCT02113878 |
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck |
https://ClinicalTrials.gov/show/NCT02113878 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2020-12-31 |
| NCT02113423 |
Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT02113423 |
Completed |
Fujian Cancer Hospital |
2009-06-30 |
| NCT02113202 |
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW |
https://ClinicalTrials.gov/show/NCT02113202 |
Completed |
University Medical Center Groningen |
2015-10-31 |
| NCT03353467 |
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT03353467 |
Recruiting |
Sun Yat-sen University |
2020-10-01 |
| NCT01937793 |
Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy |
https://ClinicalTrials.gov/show/NCT01937793 |
Completed |
National Taiwan University Hospital |
2013-12-31 |
| NCT01806675 |
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy |
https://ClinicalTrials.gov/show/NCT01806675 |
Completed |
Stanford University |
2016-12-07 |
| NCT01800071 |
A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT01800071 |
Completed |
Cancer Research UK |
2017-03-10 |
| NCT01797900 |
The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT |
https://ClinicalTrials.gov/show/NCT01797900 |
Completed |
Chinese Academy of Medical Sciences |
2014-09-30 |
| NCT01622569 |
Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety |
https://ClinicalTrials.gov/show/NCT01622569 |
Completed |
Optinose US Inc. |
2015-08-06 |
| NCT01483144 |
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) |
https://ClinicalTrials.gov/show/NCT01483144 |
Completed |
Cancer Prevention Pharmaceuticals, Inc. |
2018-11-30 |
| NCT01469429 |
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. |
https://ClinicalTrials.gov/show/NCT01469429 |
Completed |
Ohio State University Comprehensive Cancer Center |
2014-09-17 |
| NCT01393340 |
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma |
https://ClinicalTrials.gov/show/NCT01393340 |
Completed |
University Hospital, Ghent |
2008-10-31 |
| NCT04230499 |
Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance |
https://ClinicalTrials.gov/show/NCT04230499 |
Recruiting |
Rapamycin Holdings Inc. |
2022-06-30 |
| NCT04094675 |
Sirolimus for Cowden Syndrome With Colon Polyposis |
https://ClinicalTrials.gov/show/NCT04094675 |
Recruiting |
Ohio State University |
2021-12-31 |
| NCT03924986 |
Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03924986 |
Recruiting |
BeiGene |
2021-08-31 |
| NCT03890185 |
Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC |
https://ClinicalTrials.gov/show/NCT03890185 |
Active, not recruiting |
King Faisal Specialist Hospital & Research Center |
2020-12-31 |
| NCT03854838 |
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. |
https://ClinicalTrials.gov/show/NCT03854838 |
Recruiting |
Sun Yat-sen University |
2020-06-30 |
| NCT03847532 |
MUTYH-associated Polyposis |
https://ClinicalTrials.gov/show/NCT03847532 |
Recruiting |
State Scientific Centre of Coloproctology, Russian Federation |
2020-10-10 |
| NCT03840421 |
GP vs PF as Induction Chemotherapy Combined With CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03840421 |
Recruiting |
Sun Yat-sen University |
2023-02-14 |
| NCT03837808 |
Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03837808 |
Recruiting |
Sun Yat-sen University |
2022-02-11 |
| NCT03806426 |
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis |
https://ClinicalTrials.gov/show/NCT03806426 |
Recruiting |
S.L.A. Pharma AG |
2021-03-01 |
| NCT03769467 |
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) |
https://ClinicalTrials.gov/show/NCT03769467 |
Recruiting |
Atara Biotherapeutics |
2023-09-30 |
| NCT03734809 |
NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03734809 |
Recruiting |
Chinese University of Hong Kong |
2022-12-31 |
| NCT03700476 |
Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03700476 |
Recruiting |
Sun Yat-sen University |
2023-01-31 |
| NCT03688555 |
A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis |
https://ClinicalTrials.gov/show/NCT03688555 |
Active, not recruiting |
Idorsia Pharmaceuticals Ltd. |
2020-11-30 |
| NCT03687515 |
Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis. |
https://ClinicalTrials.gov/show/NCT03687515 |
Completed |
Beijing Tongren Hospital |
2016-12-03 |
| NCT03649971 |
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis |
https://ClinicalTrials.gov/show/NCT03649971 |
Recruiting |
Janssen Research & Development, LLC |
2020-09-30 |
| NCT03427827 |
Camrelizumab (PD-1 Antibody) After Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (PACIFIC-NPC) |
https://ClinicalTrials.gov/show/NCT03427827 |
Recruiting |
Sun Yat-sen University |
2022-02-28 |
| NCT01256853 |
Modified Vaccinia Ankara (MVA) Vaccine Study |
https://ClinicalTrials.gov/show/NCT01256853 |
Completed |
Chinese University of Hong Kong |
2010-09-30 |
| NCT01197612 |
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis |
https://ClinicalTrials.gov/show/NCT01197612 |
Completed |
University of Michigan |
2012-06-30 |
| NCT01187901 |
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients |
https://ClinicalTrials.gov/show/NCT01187901 |
Completed |
University of Utah |
2014-06-30 |
| NCT01094405 |
Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy |
https://ClinicalTrials.gov/show/NCT01094405 |
Active, not recruiting |
Chinese University of Hong Kong |
2021-12-31 |
| NCT00982449 |
124I-FIAU Imaging in EBV and KSHV Associated Cancers |
https://ClinicalTrials.gov/show/NCT00982449 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-07-31 |
| NCT00927485 |
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP) |
https://ClinicalTrials.gov/show/NCT00927485 |
Completed |
University of Puerto Rico |
2016-11-30 |
| NCT04296851 |
Niclosamide for Familial Adenomatous Polyposis |
https://ClinicalTrials.gov/show/NCT04296851 |
Recruiting |
Yonsei University |
2022-12-31 |
| NCT02948699 |
A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT02948699 |
Active, not recruiting |
Zhejiang Cancer Hospital |
2018-11-30 |
| NCT00808743 |
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis |
https://ClinicalTrials.gov/show/NCT00808743 |
Completed |
Radboud University |
2011-07-31 |
| NCT03791944 |
3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03791944 |
Recruiting |
Xinqiao Hospital of Chongqing |
2019-01-31 |
| NCT00770991 |
Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP) |
https://ClinicalTrials.gov/show/NCT00770991 |
Completed |
The Cleveland Clinic |
2008-09-30 |
| NCT00747799 |
Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) |
https://ClinicalTrials.gov/show/NCT00747799 |
Completed |
Sun Yat-sen University |
2011-05-31 |
| NCT00706316 |
Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer |
https://ClinicalTrials.gov/show/NCT00706316 |
Completed |
University Health Network, Toronto |
2009-08-31 |
| NCT00697619 |
To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00697619 |
Completed |
Sun Yat-sen University |
2009-01-31 |
| NCT00641147 |
Curcumin in Treating Patients With Familial Adenomatous Polyposis |
https://ClinicalTrials.gov/show/NCT00641147 |
Completed |
National Cancer Institute (NCI) |
2016-11-30 |
| NCT00630149 |
Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy |
https://ClinicalTrials.gov/show/NCT00630149 |
Completed |
Sun Yat-sen University |
2011-11-30 |
| NCT00609219 |
T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC |
https://ClinicalTrials.gov/show/NCT00609219 |
Completed |
Baylor College of Medicine |
2007-10-31 |
| NCT00603915 |
A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00603915 |
Completed |
University Health Network, Toronto |
2010-12-31 |
| NCT00565448 |
Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents |
https://ClinicalTrials.gov/show/NCT00565448 |
Completed |
Sanofi |
2009-03-31 |
| NCT00525655 |
Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP) |
https://ClinicalTrials.gov/show/NCT00525655 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-02-28 |
| NCT00510692 |
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA |
https://ClinicalTrials.gov/show/NCT00510692 |
Completed |
S.L.A. Pharma AG |
2008-04-30 |
| NCT00480298 |
Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis |
https://ClinicalTrials.gov/show/NCT00480298 |
Completed |
University Hospital, Ghent |
NA |
| NCT00439426 |
A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. |
https://ClinicalTrials.gov/show/NCT00439426 |
Completed |
Hoffmann-La Roche |
2009-09-30 |
| NCT00436800 |
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT00436800 |
Completed |
Sanofi |
2008-10-31 |
| NCT00436293 |
Taxotere + Cisplatin in Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT00436293 |
Completed |
Sanofi |
2010-03-31 |
| NCT00430378 |
Acupuncture for Prevention of Radiation-Induced Xerostomia |
https://ClinicalTrials.gov/show/NCT00430378 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-01-31 |
| NCT00408694 |
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00408694 |
Completed |
National Cancer Institute (NCI) |
2011-12-15 |
| NCT00370890 |
A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy |
https://ClinicalTrials.gov/show/NCT00370890 |
Active, not recruiting |
Chinese University of Hong Kong |
2020-12-31 |
| NCT00305734 |
Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00305734 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00188877 |
Intensity Modulated Radiation Therapy for Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00188877 |
Completed |
University Health Network, Toronto |
2008-06-30 |
| NCT00141765 |
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers |
https://ClinicalTrials.gov/show/NCT00141765 |
Completed |
University of Michigan Rogel Cancer Center |
2008-12-31 |
| NCT00123864 |
Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function |
https://ClinicalTrials.gov/show/NCT00123864 |
Completed |
AHS Cancer Control Alberta |
NA |
| NCT00101270 |
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00101270 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00091182 |
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00091182 |
Completed |
National Cancer Institute (NCI) |
2006-02-28 |
| NCT00003206 |
Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00003206 |
Completed |
Eastern Cooperative Oncology Group |
2001-07-31 |
| NCT00078546 |
EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) |
https://ClinicalTrials.gov/show/NCT00078546 |
Completed |
Baylor College of Medicine |
2007-01-31 |
| NCT00078494 |
Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00078494 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00057785 |
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00057785 |
Completed |
Radiation Therapy Oncology Group |
2007-02-28 |